Burkitt Lymphoma
Symptoms, Doctors, Treatments, Advances & More

Learn About Burkitt Lymphoma

What is the definition of Burkitt Lymphoma?

Burkitt lymphoma (BL) is a very fast growing form of non-Hodgkin lymphoma.

What are the alternative names for Burkitt Lymphoma?

B-cell lymphoma; High-grade B-cell lymphoma; Small noncleaved cell lymphoma; Burkitt's lymphoma

What are the causes of Burkitt Lymphoma?

BL was first discovered in children in certain parts of Africa. It also occurs in the United States.

The African type of BL is closely associated with the Epstein-Barr virus (EBV), the main cause of infectious mononucleosis. The North American form of BL is not commonly linked to EBV.

People with HIV/AIDS have an increased risk for this condition. BL is more common in males.

What are the symptoms of Burkitt Lymphoma?

BL may first be noticed as a swelling of the lymph nodes (glands) in the head and neck. These swollen lymph nodes are often painless, but can grow very rapidly.

In the types commonly seen in the United States, the cancer often starts in the belly area (abdomen). The disease can also start in the ovaries, testes, brain, kidneys, liver, and spinal fluid.

Other general symptoms may include:

  • Fever
  • Night sweats
  • Unexplained weight loss
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Burkitt Lymphoma?

Chemotherapy is used to treat this type of cancer. If the cancer does not respond to chemotherapy alone, a bone marrow transplant may be done.

Who are the top Burkitt Lymphoma Local Doctors?
Elite in Burkitt Lymphoma
Hematology | Oncology
Elite in Burkitt Lymphoma
Hematology | Oncology
Referral may be required

Office

219 Bryant St, 
Buffalo, NY 
Languages Spoken:
English

Matthew Barth is a Hematologist and an Oncologist practicing medicine in Buffalo, New York. Dr. Barth is rated as an Elite provider by MediFind in the treatment of Burkitt Lymphoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Primary Mediastinal B-Cell Lymphoma (PMBCL).

Elite in Burkitt Lymphoma
Elite in Burkitt Lymphoma
Referral may be required
Upper Mulago Hill Road, 
Kampala, C, UG 

Jackson Orem practices practicing medicine in Kampala, Uganda. Mr. Orem is rated as an Elite expert by MediFind in the treatment of Burkitt Lymphoma. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Burkitt Lymphoma, Kaposi Sarcoma, B-Cell Lymphoma, Tissue Biopsy, and Gastrostomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Burkitt Lymphoma
Elite in Burkitt Lymphoma
Referral may be required
Robert Koch Str. 40, 
Goettingen, NI, DE 

Lorenz Trumper practices practicing medicine in Goettingen, Germany. Mr. Trumper is rated as an Elite expert by MediFind in the treatment of Burkitt Lymphoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Peripheral T-Cell Lymphoma, B-Cell Lymphoma, Burkitt Lymphoma, and Bone Marrow Transplant.

What is the outlook (prognosis) for Burkitt Lymphoma?

More than one half of people with BL can be cured with intensive chemotherapy. The cure rate may be lower if the cancer spreads to the bone marrow or spinal fluid. The outlook is poor if the cancer comes back after a remission or does not go into remission as a result of the first cycle of chemotherapy.

What are the possible complications of Burkitt Lymphoma?

Possible complications of BL include:

  • Complications of treatment
  • Spread of the cancer
When should I contact a medical professional for Burkitt Lymphoma?

Contact your provider if you have symptoms of BL.

What are the latest Burkitt Lymphoma Clinical Trials?
A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults With Relapsed or Refractory Disease

Summary: This phase II trial studies how well inotuzumab ozogamicin and blinatumomab with or without ponatinib work in treating patients with CD22-positive B-lineage acute lymphoblastic leukemia that is newly diagnosed, has come back after a period of improvement (recurrent), or does not respond to treatment (refractory). Inotuzumab ozogamicin is a monoclonal antibody, called inotuzumab, linked to a chemot...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Tissue Procurement For Hematolymphoid Conditions

Summary: RATIONALE: Collecting and storing samples of tissue, blood, and body fluid from patients with cancer to study in the laboratory may help the study of cancer in the future. PURPOSE: This research study is collecting and storing blood and tissue samples from patients being evaluated for hematologic cancer.

Who are the sources who wrote this article ?

Published Date: May 01, 2026
Published By: Warren Brenner, MD, Oncologist, Lynn Cancer Institute, Boca Raton, FL. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.

What are the references for this article ?

Abramson JS. Non-Hodgkin lymphomas. In: Niederhuber JE, Armitage JO, Kastan MB, Doroshow JH, Tepper JE, eds. Abeloff's Clinical Oncology. 6th ed. Philadelphia, PA: Elsevier; 2020:chap 103.

Said JW. Immunodeficiency-related lymphoproliferative disorders. In: Hsi ED, Wang SA, eds. Hematopathology: Foundations in Diagnostic Pathology. 4th ed. Philadelphia, PA: Elsevier; 2026:chap 10.

Schooley RT, Allen UD. Epstein-Barr virus infection. In: Goldman L, Cooney KA, eds. Goldman-Cecil Medicine. 27th ed. Philadelphia, PA: Elsevier; 2024:chap 348.